Phase 1 trial starts next quarter.
In the meantime we will have the following newsflow leading into :
The full PK (whatever that is)
Genotoxicity study results
Safety pharmacology study results
Toxicokinetic study results
Also commentary on the optimistation of the manufacturing processes.
- Forums
- ASX - By Stock
- AGN
- ARGENICA THERAPEUTICS LIMITED IPO Analysis
ARGENICA THERAPEUTICS LIMITED IPO Analysis, page-82
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
81.0¢ |
Change
0.035(4.52%) |
Mkt cap ! $100.1M |
Open | High | Low | Value | Volume |
80.5¢ | 82.0¢ | 79.0¢ | $50.59K | 62.90K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9441 | 79.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
81.0¢ | 961 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9441 | 0.795 |
1 | 14236 | 0.790 |
1 | 6000 | 0.780 |
3 | 11134 | 0.770 |
4 | 36461 | 0.760 |
Price($) | Vol. | No. |
---|---|---|
0.810 | 961 | 1 |
0.820 | 20000 | 1 |
0.830 | 1100 | 1 |
0.850 | 10000 | 1 |
0.870 | 10000 | 1 |
Last trade - 15.52pm 26/07/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |